Why is Mono Pharmacare falling/rising?

As of 25-Sep, Mono Pharmacare Ltd's stock price is currently at 22.25, reflecting a decline of 2.0, or 8.25%. The stock has underperformed its sector by 7.39% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has decreased by 7.10%, and year-to-date, it has fallen by 35.79%. Despite a slight increase in delivery volume by 5.26% against the 5-day average, there are no available positive or negative factors to indicate a significant shift in sentiment that could counteract the downward trend.
Broader Market Context: In comparison to the benchmark Sensex, which has declined by only 2.10% over the past week, Mono Pharmacare's performance is notably weaker. The stock's year-to-date performance is significantly worse than the Sensex, which has gained 5.27% during the same period. This stark contrast highlights the challenges faced by Mono Pharmacare in the current market environment, contributing to its ongoing price decline.